VEGF as a predictor for response to definitive chemoradiotherapy and COX-2 as a prognosticator for survival in esophageal squamous cell carcinoma.
about
Clinical trial of thalidomide combined with radiotherapy in patients with esophageal cancer.Prognostic and predictive role of COX-2, XRCC1 and RASSF1 expression in patients with esophageal squamous cell carcinoma receiving radiotherapyGALNT14 genotype as a response predictor for concurrent chemoradiotherapy in advanced esophageal squamous cell carcinoma.The prognostic value of cyclooxygenase-2 expression in patients with esophageal cancer: evidence from a meta-analysis.Systematic review and meta-analysis of tumor biomarkers in predicting prognosis in esophageal cancer.Treatment outcomes of neoadjuvant concurrent chemoradiotherapy followed by esophagectomy for patients with esophageal cancer.Neoadjuvant irinotecan, cisplatin, and concurrent radiation therapy with celecoxib for patients with locally advanced esophageal cancer.New and emerging combination therapies for esophageal cancer.MMP-1/PAR-1 signal transduction axis and its prognostic impact in esophageal squamous cell carcinoma.Vascular Endothelial Growth Factor is a Useful Predictor of Postoperative Distant Metastasis and Survival Prognosis in Esophageal Squamous Cell Carcinoma.Excision repair cross-complementing group 1 (ERCC1) overexpression inhibits cell apoptosis and is associated with unfavorable prognosis of esophageal squamous cell carcinoma
P2860
Q33564241-36244419-2A03-41F7-AF36-B010DD7D8E26Q33598872-DD081985-0D98-4FC0-BB53-95679C31E489Q33710048-FAB1B4E0-DF35-409D-ACD4-E50375DCFC73Q33813283-2E551653-2CBA-41CA-9CF0-000A8564DA03Q35037270-94DE48DC-D35C-48E8-92BD-BBB03FF5CC75Q35375231-780D93DB-5054-4039-B6D8-71E502F30980Q36076749-F0840FC8-A2F5-42F1-B10D-CFD0CD5F86CEQ36996728-39BF4559-D8E0-4D50-B03D-FA2E655F6E71Q37370713-4148FF02-6B45-40EA-B23D-559E41BA5261Q41478746-409EABDB-5CEC-41F2-AF70-EFFB928FF604Q58802064-56CB08AD-FAA4-4426-B793-5D43B9CAC131
P2860
VEGF as a predictor for response to definitive chemoradiotherapy and COX-2 as a prognosticator for survival in esophageal squamous cell carcinoma.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մարտին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
VEGF as a predictor for respon ...... ageal squamous cell carcinoma.
@ast
VEGF as a predictor for respon ...... ageal squamous cell carcinoma.
@en
VEGF as a predictor for respon ...... ageal squamous cell carcinoma.
@nl
type
label
VEGF as a predictor for respon ...... ageal squamous cell carcinoma.
@ast
VEGF as a predictor for respon ...... ageal squamous cell carcinoma.
@en
VEGF as a predictor for respon ...... ageal squamous cell carcinoma.
@nl
prefLabel
VEGF as a predictor for respon ...... ageal squamous cell carcinoma.
@ast
VEGF as a predictor for respon ...... ageal squamous cell carcinoma.
@en
VEGF as a predictor for respon ...... ageal squamous cell carcinoma.
@nl
P2093
P2860
P1476
VEGF as a predictor for respon ...... ageal squamous cell carcinoma.
@en
P2093
Byung-Sik Nah
Ik-Joo Chung
Jae-Uk Jeong
Ji-Shin Lee
Ju-Young Song
Mee Sun Yoon
Sang-Hee Cho
Sung-Ja Ahn
Taek-Keun Nam
Woong-Ki Chung
P2860
P304
P356
10.3346/JKMS.2011.26.4.513
P577
2011-03-28T00:00:00Z